Sometimes I am wondering why on earth are Malaysian healthcare stocks (e.g IHH and KPJ) trading at such premium valuation (at least in terms of relative earnings yield). As shown below, both IHH and KPH are trading at a relative lower earnings yield if compared to the general KLCI index:
Further, IHH trades at a higher P/E (i.e lower earnings yield) if compared to KPJ. There has been this consistent relative premium valuation associated with IHH if compared to KPJ:
My personal view (strictly personal): I will only consider the Malaysian healthcare stocks if they trade closer to current earning yield (i.e closer to 5.0%, perhaps?) of the broader KLCI market. The more expensive you buy a stock, the less return you are going to get in the future.
DISCLAIMER: THIS IS A PERSONAL BLOG AND SHALL NOT BE RELIED IN WHATSOEVER MANNER BY ANYONE. ALL ARTICLES CONTAINED IN THIS SITE ARE STRICTLY FOR INFORMATION AND ILLUSTRATIVE PURPOSES ONLY AND DOES NOT PURPORT TO SHOW ACTUAL RESULTS. IT IS NOT, AND SHOULD NOT BE REGARDED AS INVESTMENT ADVICE OR AS A RECOMMENDATION REGARDING ANY PARTICULAR SECURITY OR COURSE OF ACTION. SOURCES USED IN THIS SITE HAVE NOT BEEN INDEPENDENTLY VERIFIED FOR ACCURACY, COMPLETENESS AND TIMELINESS. YOU SHOULD SEEK INDEPENDENT AND PROFESSIONAL INVESTMENT ADVICE IN REGARD TO YOUR INVESTMENT DECISIONS. THE AUTHOR MAY HOLD POSITIONS IN THE SECURITIES MENTIONED IN THE ARTICLES.